Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to SB 379.
Introduced
Jan 19, 2026
Last Action
Mar 10, 2026
Session
VA 2026
Sponsors
1 primary · 1 co
Governor's Action Deadline 11:59 p.m., April 13, 2026
Enrolled Bill communicated to Governor on March 10, 2026
Signed by Speaker
Fiscal Impact Statement from Department of Planning and Budget (HB1347)
Bill text as passed House and Senate (HB1347ER)
Enrolled
Signed by President
Senate substitute agreed to by House (96-Y 0-N 0-A)
Education and Health Substitute agreed to
Passed Senate with substitute Block Vote (38-Y 0-N 0-A)
Engrossed by Senate - committee substitute
Read third time
Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A)
Rules suspended
Passed by for the day (Voice Vote)
Committee substitute printed 26108278D-S1
Fiscal Impact Statement from Department of Planning and Budget (HB1347)
Reported from Education and Health with substitute (15-Y 0-N)
Senate committee offered
Constitutional reading dispensed (on 1st reading)
Referred to Committee on Education and Health
Passed House (98-Y 0-N 0-A)
Reconsideration of passage agreed to by House
Read third time and passed House (96-Y 0-N 0-A)
Read second time and engrossed
Read first time
Fiscal Impact Statement from Department of Planning and Budget (HB1347)
Reported from Health and Human Services (22-Y 0-N)
Subcommittee recommends reporting (9-Y 1-N)
Assigned sub: Health
Referred to Committee on Health and Human Services
Presented and ordered printed 26105580D
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Governor's Action Deadline 11:59 p.m., April 13, 2026